RICHTER'S TRANSFORMATION

Clinical trials for RICHTER'S TRANSFORMATION explained in plain language.

Never miss a new study

Get alerted when new RICHTER'S TRANSFORMATION trials appear

Sign up with your email to follow new studies for RICHTER'S TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1

New pill shows promise for Tough-to-Treat blood cancers

Disease control Ongoing

This study tests a new oral drug called ARQ 531 (nemtabrutinib) in about 190 people with certain blood cancers (like lymphoma or leukemia) that have returned or not responded to prior therapy. The goal is to find the safest dose and see if the drug can shrink tumors. Participants…

Matched conditions: RICHTER'S TRANSFORMATION

Phase: PHASE1, PHASE2 • Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

RICHTER'S TRANSFORMATION

Get alerted when new RICHTER'S TRANSFORMATION trials appear

New pill shows promise for Tough-to-Treat blood cancers